June 2021

Featured Article

Research Reports

US Value-Based Management of Oncology Drugs: An Explorative Study of Payer and Provider Tools to Manage the Rising Spending on Oncology Drugs

06/21/2021

Oliver Walker , PhD;

Daniele Severi-Bruni , MS;

Anne Runyan , BA;

Kolajo Salako , BS;

Anne Runyan, BA , and colleagues point out that, despite increasing cancer costs in the United States, payers’ willingness and ability to manage oncology drugs remains limited.

Anne Runyan, BA , and colleagues...

06/21/2021

Journal of Clinical Pathways

Column

Trending From ACCC

An Optimal Care Coordination Model for Medicaid Patients With Lung Cancer

06/22/2021

J Clin Pathways. 2021;7(5):24-25. In 2016, the Association of Community Cancer Centers (ACCC) embarked on a 3-year, multiphase initiative to design, test, and refine an Optimal Care Coordination Model (the Model) for Medicaid patients...

J Clin Pathways....

06/22/2021

Journal of Clinical Pathways

COA Viewpoint

Keeping Up With the Latest in Health Policy

06/22/2021

Mark Thompson ;

Mark Thompson, MD, discusses drug pricing reform under the Biden administration.

Mark Thompson, MD, discusses...

06/22/2021

Journal of Clinical Pathways

Editor's Page

Progress in Value-Based Reimbursement

06/22/2021

Winston Wong , PharmD;

Winston Wong, PharmD, discusses the articles in this issue, which include research on new payment models and payer management tools, and results from a study on the effectiveness of eribulin in subgroups of metastatic breast cancer patients...

Winston Wong, PharmD, discusses...

06/22/2021

Journal of Clinical Pathways

Pharma Insights

Value Transformation: Observations on Performance Periods 1-5 Evaluation Report of the Oncology Care Model

06/21/2021

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

Maureen Hennessey , PhD, CPCC, CPHQ;

Maureen Hennessey, PhD, CPCC, CPHQ, discusses Medicare spending as well as other performance measures related to the patient experience, management of depression and pain, emergency department and hospital use, end-of-life care, and...

Maureen Hennessey, PhD, CPCC,...

06/21/2021

Journal of Clinical Pathways

Department

Research in Review

06/21/2021

JCP Editors

J Clin Pathways. 2021;7(5):16-17. Real-World Health Care Utilization and Costs in the Huntsman at Home Program A recent study found that an oncology hospital at home program model may lower unplanned health care utilization and health...

J Clin Pathways....

06/21/2021

Journal of Clinical Pathways

Feature

Research Reports

Effectiveness of Eribulin in Metastatic Breast Cancer Patients With Poor Prognostic Indicators in the United States

06/21/2021

Bruce A. Feinberg , DO;

Talia Miller , MSW, MPH;

Jingchuan Zhang , PhD;

Marjorie E. Zettler , PhD, MPH;

Sarah S. Mougalian , MD;

A retrospective real-world study demonstrates the clinical effectiveness of eribulin in subgroups of MBC patients with poor prognostic characteristics, when used in accordance with the approved US indication.

A retrospective real-world study...

06/21/2021

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

June 2021

Featured Article

Column

Department

Feature

Current Issue

Special Reports

Subscribe

June 2021 Volume 7 Issue 5

Specialties

Events

Year Round Education

HMP Global Products